Lyka Labs Ltd. — Audit Report / Information 2025

Jul 17, 2024

Healthcare Through Innovation

Ly�a La s Limited

Corporate Office : Gr und floor, Spencer Building, 30, Forjett Street, Grant Road (West), Mumbai - 400 036 o Phone: 6611 22001 90 Website: w.lykalabs.com w o Email: enquiry@lykalabs.com

BSE Li ited National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Dalal S reet, Plot No. C/1, G. Block, Mumb i 400 001. Bandra Kurla Complex, Bandra (East), Mumbai 400 051.

Script Code: L YKALABS

Dear Si /Madam,

Sub.: econciliation of Share Capital Audit Report under Regulation 76 of SEBI (Depos"tories and Participants) Regulation, 2018

Pursua t to Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018; we are enc osing herewith Reconciliation of Share Capital Audit Report for the quarter ended 30th Ju e 2024.

Kindly ake the same on your record.

Thanki g You, Yours f ithfully,

Kishore Prafullchandra Shah Digitally signed by Kishore Prafullchandra Shah DN: c=IN, o=Personal, title=9560, pseudonym=1331297515965628135xOch72eRUrK2x, 2.5.4.20=de08135ca4524d97ad933e4623b164807ebd92bde60e210e2e0df5f4492070aa, postalCode=411040, st=Maharashtra, serialNumber=20494e559c02fd30f34c4cd836e8a7b39e60f83be45237f1143053acd4a3f548, cn=Kishore Prafullchandra Shah Date: 2024.07.17 15:31:58 +05'30' Kishor P. Shah Compa y Secretary & Compliance Officer

Regd. Office: 4801 I B & 4802 I A, G.I.D.C. Industrial Estate, Ankleshwar- 393 002. o Phone: 02646 221422 I 220549 o Fax: 02640-250692 GIN L24230GJ1976PLC008738

Kaushal Doshi & Associates

Practicing Company Secretary

A/39, Ashok Samrat, Daftary Road, Malad (E), Mumbai – 400 097 Mobile No.: +91-9892 368 648/8879061581 Email : doshikaushal20@gmail.com

==> picture [85 x 51] intentionally omitted <==

RECONCILIATION OF SHARE CAPITAL AUDIT

(As per Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018)

1	For the Quarter Ended	30thJune, 2024	30thJune, 2024	30thJune, 2024
2	ISIN	INE933A01014
3	Face Value	Rs. 10/-pershare
4	Name of company	Lyka Labs Limited
5	Registered OfficeAddress	4801/B&4802/A, GIDCIndustrial Estate,Ankleshwar393 002.
6	Correspondence Address	Spencer Building, Ground Floor, 30 Forjett Street, Tardeo, Grant Road West,Mumbai 400 036.
7	Telephone	Tel No. 022 6611 2200
8	e-mail address	companysecretary@lykalabs.com
9	Names of the stock exchanges, where the company’s securities are listed			-BSE Limited -National Stock Exchange of India Limited
			No.ofshares	% oftotal issued capital
10	Issued Capital: Equity (Rs. 10 each)		35690000	100.00
	Preference (Rs. 100 each)		108570
11	Listed Capital (Exchange-wise) BSE		35690000	99.70
	NSE		35690000	99.70
12	Held in dematerialized form in CDSL		25147152	70.25
13	Held in dematerialized form in NSDL		7728178	21.59
14	Physical		2814670	7.86
15	Total No. of shares (12+13+14)		35690000	99.70
16	Reasons for difference, if any, between (10&11), (10&15), (11&15)			The company has 108570 Preference Shares of Rs.100/-each. The same is not listed on any stock exchange. The company has issued and allotted 2600000 equity shares of Rs.10/- each at premium of Rs.129.50/- pursuant to conversion of 2600000 warrants on preferential basis, the Listing Application thereof is in process with the BSE limited and the National Stock Exchange of India Limited.

17 Certifying the details of changes in share capital during the quarter under consideration as per Table below

17	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below	Certifying the details of changes in share capital during the quarter under consideration as per Table below
*Particular s		No. of shares	Applied for listing	Listed in Stock Exchanges (specify names)	Whether intimated to CDSL	Whether intimate d to NSDL	In- principle Approval Pending from SE
conversion		2600000	Applied	BSE Limited and the National Stock Exchange of India Limited	Yes	Yes	No

*The company has issued and allotted 2600000 equity shares of Rs.10/- each at premium of Rs.129.50/pursuant to conversion of 2600000 warrants on preferential basis., the Listing Application thereof is in process with the BSE limited and the National Stock Exchange of India Limited.

18	Registerof membersis updated (Yes/No)	Registerof membersis updated (Yes/No)	Registerof membersis updated (Yes/No)	YES	YES
	If not, updated, up to, which date.			N.A.
19	Reference of previous quarter with regards to excess dematerialized shares, if any.			N.A.
20	Has the company resolved the matter mentioned in point no. 19 above in the current quarter? If not, reason why?			N.A.
21	Mention the total no. of requests, if any, confirmed after 21 days and the total no. of requests pending beyond 21 days, with the reasons for delay.
Total no. of Demat requests		No. of requests	No. of shares		Reasons for delay
Confirmed after 21days		NIL	NIL		N.A.
Pending for more than 21 days		NIL	NIL		N.A.
22	Name, telephone & Fax No. of the Compliance Officer of the company	Mr. Kishore P. Shah Membership No- A20792 Company Secretary & Compliance Officer Tel No. 8657524774. e-mail. companysecretary@lykalabs.com
23	Name, address, Tel. No., Fax No. & Regn. No. of the Auditor of the company	Mr. Kaushal Doshi Kaushal Doshi & Associates Practicing Company Secretary, Membership No: F10609, COP: 13143 Address: #A/39, Ashok Samrat, Daftary Road, Malad (E), Mumbai- 400 097, Maharashtra. Tel: +91-9892368648 e-mail: doshikaushal20@gmail.com
24	Appointment of common agency for share registry work (if yes, name & address).	Link Intime India Private Limited C -101, 247 Park, L B S Marg, Vikhroli West, Mumbai-400 083, Maharashtra.
25	Any other details that the auditor may like to provide (e.g. BIFR, company delisting from SE etc.)	Not Applicable

For Kaushal Doshi & Associates Practicing Company Secretary

KAUSHAL Digitally signed by KAUSHAL DHIRENDRA DHIRENDRA DOSHI Date: 2024.07.17 12:43:44 DOSHI +05'30'

Kaushal Doshi

Proprietor FCS: 10609/ COP: 13143 PR Number: 802/2020 UDIN: F010609F000758158

Date: 17[th] July, 2024

Place: Mumbai